Product Information
GLYCOPYRROLATE 0.2 MG/ML VIAL is a generic product labeled by Athenex Pharmaceutical Division, LLC., priced at $1.5137 per ML under NDC 70860078101. Its NADAC has been published 63 times since Dec 18, 2024.
FDA first approved this application on Feb 21, 2020. Its Orange Book therapeutic-equivalence code is AP.
Strength
.2 mg/mL
Manufacturer
Athenex Pharmaceutical Division, LLC.NDC
70860078101
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
8/20/2025
Active Ingredients
GLYCOPYRROLATEApproval Type
Generic (ANDA)
FDA Application
ANDA210083FDA Approved
2/21/2020
TE Code
AP
On Market Since
1/31/2023
Pharmacological Classes
Price Statistics
The NADAC for GLYCOPYRROLATE 0.2 MG/ML VIAL has been published 63 times since Dec 18, 2024, and over the history we have for it it has risen 8.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5137 per ML |
|---|---|
| All-time high | $1.5856 (Aug 13, 2025) |
| All-time low | $1.3976 (Dec 18, 2024) |
| 52-week high | $1.5137 |
| 52-week low | $1.5137 |
| Median price | $1.5137 |
| Average price | $1.4972 |
| Largest weekly change | +5.6% (Jan 22, 2025) |
| Weeks tracked | 63 |
| Tracking since | Dec 18, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
N/A
5Y
N/A
All
+8.3%
Last surveyed Feb 25, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Athenex Pharmaceutical Division, LLC. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
glycopyrrolate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GLYCOPYRROLATE 0.2 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for GLYCOPYRROLATE 0.2 MG/ML VIAL, manufactured by Athenex Pharmaceutical Division, LLC., is $1.5137 per ML (NDC 70860078101), effective Feb 25, 2026.
How has the price of GLYCOPYRROLATE 0.2 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for GLYCOPYRROLATE 0.2 MG/ML VIAL has risen 8.3%. It has been tracked across 63 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for GLYCOPYRROLATE 0.2 MG/ML VIAL?
Since Dec 18, 2024, the NADAC for GLYCOPYRROLATE 0.2 MG/ML VIAL has ranged from a low of $1.3976 (Dec 18, 2024) to a high of $1.5856 (Aug 13, 2025), with a median of $1.5137 per ML.
Are there cheaper alternatives to GLYCOPYRROLATE 0.2 MG/ML VIAL?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GLYCOPYRROLATE 0.2 MG/ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures GLYCOPYRROLATE 0.2 MG/ML VIAL?
GLYCOPYRROLATE 0.2 MG/ML VIAL (NDC 70860078101) is labeled by Athenex Pharmaceutical Division, LLC., and CMS classifies it as a generic product.